GeneXpert Sales to VA Boost Cepheid’s Q3 Results; New MRSA Test to Launch in 2008 | GenomeWeb
This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
Cepheid officials said last week that sales of the company’s GeneXpert system and test cartridges, particularly to hospitals in the US Veterans Administration network, pushed its third-quarter revenues up 53 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.